Cytek Biosciences share price logo

Cytek Biosciences

NASDAQ: CTKB

Small Cap

$5.34

-0.04

(-0.74%)

as on

Cytek Biosciences Stock Performance

as on October 8, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $5.12
    $5.33
    downward going graph

    4.12%

    Downside

    -0.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.31
    $6.21
    downward going graph

    38.01%

    Downside

    16.29%

    Upside

    downward going graph

Cytek Biosciences share price movements today

Previous Close
$5.38
Open
$5.24
Volume
1.8M
Market Cap
$699.3M
Day's Low - High
$5.12 - $5.33
52 Week Low - High
$3.31 - $6.21

Cytek Biosciences Historical Returns

1 Month Return
+ 15.58 %
3 Month Return
+ 21.64 %
1 Year Return
+ 36.92 %
3 Year Return
-0.37 %
5 Year Return
-75.32 %

Cytek Biosciences Stock Fundamentals & Key Indicators

Check Cytek Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$699.3M

EPS (TTM)

-0.62

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.73%

PE Ratio (TTM)

-8.64

Industry PE ratio

-6.95

PEG Ratio

0.07

EBITDA

-27.2M

Revenue (TTM)

206.7M

Profit Margin

53.23%

Return On Equity TTM

-23.53%

Cytek Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytek Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$699.3M-75.32%-8.6453.23%0.00%
Buy$49.8B-21.11%49.7077.98%0.00%
Buy$112.5B-31.74%21.2966.69%3.28%
StrongBuy$109.4B4.44%28.6265.17%1.27%
StrongBuy$168.7B-16.75%32.1956.80%2.48%

Stock Returns calculator for Cytek Biosciences Stock including INR - Dollar returns

The Cytek Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Cytek Biosciences investment value today

Current value as on today

₹1,49,322

Returns

₹49,322

(+49.32%)

Returns from Cytek Biosciences Stock

₹36,923 (+36.92%)

Dollar Impact

₹12,399 (+12.4%)

Analyst Recommendation on Cytek Biosciences Stock

Based on 3 analysts

BUY

33.33%

Buy

66.67%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Cytek Biosciences. Average target price of $5.56

Cytek Biosciences Share Price Target

Get share price movements and forecasts by analysts on Cytek Biosciences.

What analysts predicted

3.96%UPSIDE

Target Price

$5.56

Current Price

$5.34

Analyzed by

3 Analysts

High

$7.5

Target

$5.56

Low

$5

Cytek Biosciences target price $5.56, a slight upside of 3.96% compared to current price of $5.34. According to 3 analysts rating.

Indian Investors' Interest in Cytek Biosciences Stock

Search interest for Cytek Biosciences Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:88% versus previous 30 day period

Cytek Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
44
46
51
57
41
45
52
62
44
48
Gross Profit
23
25
29
33
20
23
27
32
21
28
Operating Income
-10
-8
-4
2
-14
-10
-9
-5
-18
-11
EBITDA
-6
-4
3
-2
-8
-3
-4
0
-14
-8
Interest Expense
0
0
0
-
0
0
0
0
0
0
Depreciation
2
2
2
2
2
2
3
3
2
2
Income Before Tax
-8
-7
0
10
-11
-6
-7
-4
-17
-11
Income Tax Expense
-2
3
0
0
0
-1
-2
40
1
0
Net Income
-6
-10
0
9
-11
-5
-5
-44
-18
-12
Net Profit Margin
51.30%
54.56%
56.32%
58.55%
48.62%
52.34%
52.69%
52.92%
48.16%
58.87%

Cytek Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
57
92
127
164
193
200
201
Gross Profit
28
51
79
100
109
111
104
Operating Income
-17
13
9
-1
-27
-20
-40
EBITDA
-15
15
8
9
-4
4
-17
Interest Expense
0
0
1
2
2
-
0
Depreciation
0
0
1
5
9
10
11
Income Before Tax
-16
14
5
1
-15
-5
-29
Income Tax Expense
0
-4
2
-1
-3
0
36
Net Income
-16
19
3
2
-12
-6
-66
Net Profit Margin
49.54%
55.70%
61.86%
61.56%
56.69%
55.43%
51.84%

Cytek Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-10
0
9
-11
-5
-5
-44
-18
-12
Operating Cash Flow
3
6
13
1
0
0
-3
0
-2
1
Investing Cash Flow
-5
2
-15
-63
9
-16
18
-1
-27
7
Financing Cash Flow
1
-1
-12
-3
-11
-2
1
-1
3
0
Change in Cash
1
8
-15
-63
-3
-19
17
-2
-25
8

Cytek Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
19
3
2
-12
-6
-66
Operating Cash Flow
-13
15
4
-12
5
25
-4
Investing Cash Flow
0
-1
-20
-55
-93
-82
10
Financing Cash Flow
0
122
213
5
-41
-15
-13
Change in Cash
-14
135
198
-65
-131
-68
-7

Global Institutional Holdings in Cytek Biosciences

Check out the Institutions with significant holdings in Cytek Biosciences.

Funds
Holdings
Vanguard
4.60%
iShares
4.35%
VANGUARD INDEX FUNDS
3.57%
Chuck Royce
1.60%
DFA INVESTMENT DIMENSIONS GROUP INC
1.03%

Insights on Cytek Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -44.07M → -12.15M (in $), with an average increase of 94.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CTKB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 44.13M → 48.13M (in $), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 16.4% return, outperforming this stock by 16.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CTKB stock has moved down by -8.1%

About Cytek Biosciences

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
OrganisationCytek Biosciences
Headquarters47215 Lakeview Boulevard, Fremont, CA, 94538-6407, US
IndustryMedical - Devices
CEOWenbin Jiang

Key Management of Cytek Biosciences

Name

Title

Dr. Wenbin Jiang Ph.D.

President, CEO & Chairman of the Board

Mr. William D. McCombe

Chief Financial Officer

Dr. Ming Yan Ph.D.

CTO & Director

Mr. Paul D. Goodson

Head of Investor Relations

Mr. Ilan B. Feuchtwang

Chief Legal Officer

Mr. Patrik Sebastian Jeanmonod

Head of Corporate Development Analytics

FAQs

What is Cytek Biosciences share price today?

Cytek Biosciences share price today is $5.34 as on at the close of the market. Cytek Biosciences share today touched a day high of $5.33 and a low of $5.12.

What is the 52 week high and 52 week low for Cytek Biosciences share?

Cytek Biosciences share touched a 52 week high of $6.21 on and a 52 week low of $3.31 on . Cytek Biosciences stock price today i.e. is closed at $5.34,which is 14.01% down from its 52 week high and 61.33% up from its 52 week low.

What is Cytek Biosciences's market capitalisation today?

Cytek Biosciences market capitalisation is $0.00T as on .

How to invest in Cytek Biosciences Stock (CTKB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytek Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cytek Biosciences Stock (CTKB) from India?

Indian investors can start investing in Cytek Biosciences (CTKB) shares with as little as ₹96.775001525879 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.75 in Cytek Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytek Biosciences share’s latest price of $5.34 as on October 8, 2026 at 8:46 am IST, you will get 1.8727 shares of Cytek Biosciences. Learn more about fractional shares .

What are the returns that Cytek Biosciences has given to Indian investors in the last 5 years?

Cytek Biosciences stock has given -75.32% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?